Invention Grant
- Patent Title: Targeted vectors for cancer immunotherapy
- Patent Title (中): 用于癌症免疫治疗的靶向载体
-
Application No.: US12724317Application Date: 2010-03-15
-
Publication No.: US08828378B2Publication Date: 2014-09-09
- Inventor: Erlinda M. Gordon , Frederick L. Hall
- Applicant: Erlinda M. Gordon , Frederick L. Hall
- Applicant Address: US CA Los Angeles
- Assignee: The University of Southern California
- Current Assignee: The University of Southern California
- Current Assignee Address: US CA Los Angeles
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K48/00 ; A01N63/00
Abstract:
This invention provides compositions and methods for treating cancer. More specifically this invention is directed to a targeted retroviral vector comprising a cytokine gene that can be administered either alone or in combination with a targeted retroviral vector comprising a cytocidal gene for treating cancer in a subject. Also provided are a kit or drug delivery system comprising the compositions for use in the methods described.
Public/Granted literature
- US20100233127A1 TARGETED VECTORS FOR CANCER IMMUNOTHERAPY Public/Granted day:2010-09-16
Information query
IPC分类:
